The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer
Authors
Keywords
Platelet to lymphocyte ratio, Platelet, Lymphocyte, Colorectal cancer, Stage II
Journal
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
Volume 30, Issue 9, Pages 1165-1171
Publisher
Springer Nature
Online
2015-06-06
DOI
10.1007/s00384-015-2276-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients
- (2014) Joanna Szkandera et al. AMERICAN JOURNAL OF SURGERY
- Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer
- (2014) X. Xie et al. DISEASES OF THE ESOPHAGUS
- The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients
- (2014) Hou-Qun Ying et al. MEDICAL ONCOLOGY
- Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor
- (2014) Kyriakos Neofytou et al. MEDICAL ONCOLOGY
- Independent Validation of a Prognostic Genomic Signature (ColoPrint) for Patients With Stage II Colon Cancer
- (2013) Matthias Maak et al. ANNALS OF SURGERY
- Preoperative Plasma Hyperfibrinogenemia is Predictive of Poor Prognosis in Patients with Nonmetastatic Colon Cancer
- (2013) Hae-Jung Son et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy
- (2013) Suee Lee et al. BMC CANCER
- Postoperative Detection of Circulating Tumor Cells Predicts Tumor Recurrence in Colorectal Cancer Patients
- (2013) Gennaro Galizia et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis
- (2013) Jia-Xing Zhang et al. LANCET ONCOLOGY
- Colorectal cancer and hypercoagulability
- (2013) Kazushige Kawai et al. SURGERY TODAY
- The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer
- (2013) Valéria Jósa et al. THROMBOSIS AND HAEMOSTASIS
- Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer
- (2012) Supachai Raungkaewmanee et al. Journal of Gynecologic Oncology
- Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy
- (2011) N. Cézé et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features
- (2011) Erin S. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Preoperative Thrombocytosis on the Survival of Patients with Primary Colorectal Cancer
- (2011) Kazuhito Sasaki et al. WORLD JOURNAL OF SURGERY
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer
- (2010) Joji Kitayama et al. Radiation Oncology
- Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
- (2008) Richard A. Smith et al. AMERICAN JOURNAL OF SURGERY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started